Although breast cancer research funding covers many areas of prevention and treatment, it doesn’t properly address needs for those with stage 4 cancer.
Metastatic breast cancer (MBC), also known as stage 4 cancer, is incurable and is responsible for the deaths of nearly everyone who dies from breast cancer. MBC is when the cancer has spread outside the breast to other parts of the body — typically the bones, lungs, liver or brain. A recent study estimates that as of January 2017 there are nearly 155,000 women living with MBC in the United States alone and about 25 percent of them were diagnosed at stage 4 from the beginning; the other 75 percent progressed to stage 4 from an initial earlier diagnosis.
Read the entire article at: Why Metastatic Breast Cancer Research Needs More Funding